Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've been researching how to reconstitute tirzepatide at 30mg, you've likely come across vials, powders and mixing guides circulating online. The short answer: 30mg is not a licensed dose of tirzepatide in the UK, and reconstituting tirzepatide at home from powder is not part of how the medicine is supplied or prescribed here. Tirzepatide is licensed in the UK under the brand name Mounjaro, supplied as a pre-filled, ready-to-inject KwikPen — no mixing, no measuring, no reconstitution required. The licensed strengths run from 2.5mg up to 15mg per weekly injection, and every pen arrives pre-dosed and ready to use straight from the fridge. If you've seen 30mg tirzepatide described as a reconstituted dose, that content almost certainly originates outside the UK licensed framework and shouldn't be followed here.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've done your research. You've seen guides explaining how to reconstitute tirzepatide at 30mg, measured into a vial with bacteriostatic water, drawn up with a fresh syringe, injected subcutaneously. The instructions look clinical. The vendor has a professional-looking website. None of this means the product is legal, safe, or even what it claims to be.
In the UK, tirzepatide has a marketing authorisation granted by the MHRA. That authorisation covers specific strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, all supplied in pre-filled KwikPens by Eli Lilly. There is no licensed 30mg dose. There is no reconstitution step. Any product positioned as "tirzepatide powder" for home mixing sits entirely outside the licensed UK supply chain and has not been reviewed for quality, potency or sterility by any UK regulator. The NHS medicines information for tirzepatide describes a ready-to-use injection, because that is what the licensed product is.
A quick check you can do in under a minute: search the product name on the MHRA's online register. If it doesn't appear there with a current UK marketing authorisation, it has no legal basis for sale as a medicine in this country. Worth doing before anything else.
The 30mg figure tends to appear in content produced for markets where compounded or research-grade tirzepatide is available, particularly the United States, where compounding pharmacies operated under different rules during the semaglutide shortage period. It has nothing to do with UK licensed doses or UK prescribing practice.
In some of these protocols, a vial of tirzepatide peptide powder is mixed with a diluent to create a concentration, and our guide to 30mg tirzepatide reconstitution explains why this approach has never been approved by UK regulators, carries unpredictable dosing risks, and requires sterile technique that simply cannot be replicated safely in a domestic kitchen or bathroom.
There's a broader safety issue too. The MHRA has confirmed that fake weight-loss pens and unlicensed peptide preparations have been seized in substantial quantities across the UK, including the first UK raid on a site manufacturing counterfeit tirzepatide pens in Northampton in October 2025. These products have, in some cases, been found to contain entirely different substances. If you're reading about reconstituted tirzepatide in any form, this context matters.
Licensed tirzepatide treatment in the UK begins at 2.5mg, a starting dose that lets the body adjust before the prescriber steps the dose upward, typically in four-week intervals. The pen for each strength is a self-contained device: no drawing up, no mixing, no guesswork about concentration. You dial the pen, press the button, and the dose is delivered. Full preparation and storage guidance is in the Patient Information Leaflet that comes with every pen, and the Mounjaro SmPC on the eMC carries the prescriber-level detail.
This matters practically: a pre-filled pen from a licensed, verifiable supply chain gives you certainty about what you're injecting, at what dose, with what sterility standards. A reconstituted preparation from an unlicensed source gives you none of those assurances. For a detailed look at what UK-licensed tirzepatide treatment involves, our tirzepatide overview covers the mechanism, the clinical evidence and the licensed dose pathway.
Cost is sometimes the reason people explore unlicensed routes. Private Mounjaro prices in the UK have risen since Eli Lilly adjusted list pricing in September 2025, and it's reasonable to feel the difference. Our Mounjaro cost guide sets out what's included in a legitimate private price (prescription, clinical review, delivery and aftercare) and why the cheapest listing is rarely the right test when you're choosing a prescription medicine.
Tirzepatide is a Prescription-Only Medicine. The legal route to it is a prescription following a clinical assessment by a qualified prescriber who reviews your health history, your BMI, any relevant conditions, and your current medicines. That isn't a formality, it's the step that makes the treatment safe and appropriate for you specifically.
If you've been looking into home reconstitution of tirzepatide because you assumed it was cheaper or easier to access, a legitimate online consultation may be simpler than you expect. You can explore how UK-licensed weight-loss treatment works, and our frequently asked questions cover the steps from eligibility to delivery in plain terms.
At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not software) on the same day you submit it. Medicines are dispensed from our own GPhC-registered UK pharmacy (registration 9012878, verifiable at pharmacyregulation.org), sourced through the licensed UK supply chain. If approved, orders placed before 12pm are dispatched the same day and delivered free by DPD the next working day. That's the actual alternative to an unverified online vendor, and it starts with a conversation, not a purchase.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.